These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16531749)

  • 1. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease.
    López-Miranda J; Pérez-Martínez P; Marín C; Moreno JA; Gómez P; Pérez-Jiménez F
    Curr Opin Lipidol; 2006 Apr; 17(2):132-8. PubMed ID: 16531749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism.
    Lopez-Miranda J; Williams C; Lairon D
    Br J Nutr; 2007 Sep; 98(3):458-73. PubMed ID: 17705891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal lipoprotein overproduction in insulin-resistant states.
    Adeli K; Lewis GF
    Curr Opin Lipidol; 2008 Jun; 19(3):221-8. PubMed ID: 18460911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease.
    Rifai N
    Arch Pathol Lab Med; 1986 Aug; 110(8):694-701. PubMed ID: 3524505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk.
    Su JW; Nzekwu MM; Cabezas MC; Redgrave T; Proctor SD
    Eur J Clin Invest; 2009 Sep; 39(9):741-54. PubMed ID: 19563468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoproteins: metabolic role and clinical biochemistry applications.
    Dominiczak MH; Caslake MJ
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):498-515. PubMed ID: 22028427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance.
    Nierman MC; Rip J; Kuivenhoven JA; van Raalte DH; Hutten BA; Sakai N; Kastelein JJ; Stroes ES
    Metabolism; 2005 Nov; 54(11):1499-503. PubMed ID: 16253639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability.
    Helwig U; Rubin D; Klapper M; Li Y; Nothnagel M; Fölsch UR; Döring F; Schreiber S; Schrezenmeir J
    Metabolism; 2007 Jun; 56(6):723-31. PubMed ID: 17512303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network approach to micronutrient genetics: interactions with lipid metabolism.
    Lietz G; Hesketh J
    Curr Opin Lipidol; 2009 Apr; 20(2):112-20. PubMed ID: 19276889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology for studying postprandial lipid metabolism.
    Lairon D; Lopez-Miranda J; Williams C
    Eur J Clin Nutr; 2007 Oct; 61(10):1145-61. PubMed ID: 17457341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antidiabetic drugs on genes regulating lipid metabolism.
    Tomkin GH
    Curr Opin Lipidol; 2009 Feb; 20(1):10-6. PubMed ID: 19106706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peculiarities of postprandial activity of lipoprotein lipase in coronary heart disease].
    Svanidze NO; Kavtaradze GV; Shaburishvili TSh; Dzhavashvili LV; Tananashvili DE
    Georgian Med News; 2007 Apr; (145):49-52. PubMed ID: 17525500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins AI and B as therapeutic targets.
    Charlton-Menys V; Durrington P
    J Intern Med; 2006 May; 259(5):462-72. PubMed ID: 16629852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exercise in minimizing postprandial oxidative stress in cigarette smokers.
    Bloomer RJ; Fisher-Wellman K
    Nicotine Tob Res; 2009 Jan; 11(1):3-11. PubMed ID: 19246436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.
    Dallinga-Thie GM; Dullaart RP; van Tol A
    Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.